Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy.
Thomson
A W
AW
Department of Surgery, University of Pittsburgh Medical Center, Pennsylvania 15213.
Woo
J
J
Lemster
B
B
Irish
W
W
Huang
L L
LL
Carroll
P B
PB
Rilo
H R
HR
Abu-Elmagd
K
K
Eidelman
B
B
D000328:Adult; D016516:CD4-CD8 Ratio; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D005260:Female; D006801:Humans; D017493:Leukocyte Common Antigens / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D016559:Tacrolimus / Q000627:therapeutic use*
D015375:Receptors, Interleukin-2; D017493:Leukocyte Common Antigens; D016559:Tacrolimus